ACTUATE THERAPEUTICS, INC. (ACTU)

Nasdaq · Pharmaceutical Preparations · Inc. DE

What they're doing

Not enough recent activity to summarise.

Signals, last 12 months

  1. Material 8-K filing
    Filed 8-K disclosing director or officer change
  2. Large insider sale
    THOMSON TODD S (director) sold $1.6M of stock
  3. Material 8-K filing
    Filed 8-K disclosing material agreement

Insider transactions

DateInsiderRoleCodeSharesPriceValue
2026-02-13SCHMITT DANIEL MdirectorF121,8744.33$527,714
2026-02-13SCHMITT DANIEL MdirectorM272,0550$0
2026-01-05THOMSON TODD SdirectorS280,0005.8$1,624,000
2025-06-27Bios Equity COF, LPdirectorP71,4287$499,996
2025-06-27BIOS Fund II, LPdirectorP71,4287$499,996
2025-06-27BIOS Actuate Co-Invest I, LPdirectorP71,4287$499,996
2024-08-14BIOS Fund II QP, LPdirectorC61,857
2024-08-14BIOS Fund II QP, LPdirectorC462,073
2024-08-14BIOS Fund II QP, LPdirectorC141,457
2024-08-14BIOS Fund II QP, LPdirectorC307,538
2024-08-14BIOS Fund II QP, LPdirectorC525,797
2024-08-14BIOS Fund II QP, LPdirectorP125,0008$1,000,000
2024-08-14BIOS Fund II QP, LPdirectorP375,0008$3,000,000
2024-08-14BIOS Fund II QP, LPdirectorC884,427
2024-08-14BIOS Fund II QP, LPdirectorS2,3249$20,916
2024-08-14BIOS Fund II QP, LPdirectorX3,5285.27$18,593
2024-08-14BIOS Fund II QP, LPdirectorS17,3619$156,249
2024-08-14BIOS Fund II QP, LPdirectorX26,3555.27$138,891
2024-08-14BIOS Fund II QP, LPdirectorS5,3149$47,826
2024-08-14BIOS Fund II QP, LPdirectorX8,0685.27$42,518
2024-08-14BIOS Fund II QP, LPdirectorC573,394
2024-08-14BIOS Fund II QP, LPdirectorC78,267
2024-08-14BIOS Fund II QP, LPdirectorC484,638
2024-08-14Bios Clinical Opportunity Fund, LPdirectorS2,3248$18,592
2024-08-14Bios Clinical Opportunity Fund, LPdirectorS17,3618$138,888
2024-08-14Bios Clinical Opportunity Fund, LPdirectorS5,3148$42,512
2024-08-14BIOS Capital Management, LPdirectorS2,3248$18,592
2024-08-14BIOS Capital Management, LPdirectorS5,3148$42,512
2024-08-14BIOS Capital Management, LPdirectorS17,3618$138,888
2024-08-14BIOS Fund II, LPdirectorS2,3248$18,592
2024-08-14BIOS Fund II, LPdirectorS5,3148$42,512
2024-08-14BIOS Fund II, LPdirectorS17,3618$138,888
2024-08-14Kairos-Actuate SPV, L.P.directorC146,870
2024-08-14Kairos-Actuate SPV, L.P.directorC230,597
2024-08-14Kairos-Actuate SPV, L.P.directorC138,889
2024-08-14Kairos-Actuate SPV, L.P.directorC726,163
2024-08-14Kairos-Actuate SPV, L.P.directorC1,058,318
2024-08-14Kairos-Actuate SPV, L.P.directorC69,445
2024-08-14Kairos-Actuate SPV, L.P.directorC132,908
2024-08-14Kairos-Actuate SPV, L.P.directorC24,138
2024-08-14Kairos-Actuate SPV, L.P.directorC49,984
2024-08-14Kairos-Actuate SPV, L.P.directorX28,4645.27$150,005
2024-08-14Kairos-Actuate SPV, L.P.directorS18,7508$150,000
2024-08-14BIOS Equity Partners III, LPdirectorC525,797
2024-08-14BP Directors, LPdirectorC78,267
2024-08-14BP Directors, LPdirectorC484,638
2024-08-14BP Directors, LPdirectorX8,0685.27$42,518
2024-08-14BP Directors, LPdirectorS5,3149$47,826
2024-08-14BP Directors, LPdirectorX26,3555.27$138,891
2024-08-14BP Directors, LPdirectorS17,3619$156,249

Federal contracts

No federal contract actions on record for this recipient mapping.

Lobbying

No federal lobbying filings on record for this client mapping.

Public attention

No Wikipedia pageview data linked to this company.

Recent filings